nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—GRIK3—seminal vesicle—testicular cancer	0.0183	0.136	CbGeAlD
Topiramate—GRIK4—testis—testicular cancer	0.013	0.0972	CbGeAlD
Topiramate—GRIK1—female gonad—testicular cancer	0.0102	0.0759	CbGeAlD
Topiramate—GRIK5—testis—testicular cancer	0.00951	0.0709	CbGeAlD
Topiramate—GRIK3—testis—testicular cancer	0.00951	0.0709	CbGeAlD
Topiramate—GRIA3—testis—testicular cancer	0.0084	0.0626	CbGeAlD
Topiramate—GRIA2—embryo—testicular cancer	0.00728	0.0543	CbGeAlD
Topiramate—GRIK5—lymph node—testicular cancer	0.00689	0.0514	CbGeAlD
Topiramate—GRIK3—lymph node—testicular cancer	0.00689	0.0514	CbGeAlD
Topiramate—GRIA1—testis—testicular cancer	0.00448	0.0334	CbGeAlD
Topiramate—CA9—testis—testicular cancer	0.00406	0.0303	CbGeAlD
Topiramate—CA5B—gonad—testicular cancer	0.00374	0.0279	CbGeAlD
Topiramate—CA4—seminal vesicle—testicular cancer	0.00357	0.0267	CbGeAlD
Topiramate—GRIA2—testis—testicular cancer	0.00356	0.0266	CbGeAlD
Topiramate—CA2—embryo—testicular cancer	0.00316	0.0235	CbGeAlD
Topiramate—CA2—seminal vesicle—testicular cancer	0.00296	0.0221	CbGeAlD
Topiramate—CA5B—testis—testicular cancer	0.0027	0.0201	CbGeAlD
Topiramate—GABRB2—testis—testicular cancer	0.00253	0.0189	CbGeAlD
Topiramate—CA4—female gonad—testicular cancer	0.0021	0.0157	CbGeAlD
Topiramate—CA5B—lymph node—testicular cancer	0.00195	0.0146	CbGeAlD
Topiramate—CA4—testis—testicular cancer	0.00186	0.0139	CbGeAlD
Topiramate—CA2—female gonad—testicular cancer	0.00174	0.013	CbGeAlD
Topiramate—CA1—lymph node—testicular cancer	0.00173	0.0129	CbGeAlD
Topiramate—CA2—testis—testicular cancer	0.00154	0.0115	CbGeAlD
Topiramate—CA4—lymph node—testicular cancer	0.00135	0.0101	CbGeAlD
Topiramate—CA2—lymph node—testicular cancer	0.00112	0.00834	CbGeAlD
Topiramate—Tinnitus—Methotrexate—testicular cancer	0.000298	0.000344	CcSEcCtD
Topiramate—Hypoaesthesia—Epirubicin—testicular cancer	0.000298	0.000344	CcSEcCtD
Topiramate—Asthenia—Cisplatin—testicular cancer	0.000297	0.000343	CcSEcCtD
Topiramate—Pharyngitis—Epirubicin—testicular cancer	0.000297	0.000343	CcSEcCtD
Topiramate—Cardiac disorder—Methotrexate—testicular cancer	0.000297	0.000343	CcSEcCtD
Topiramate—Urinary tract disorder—Epirubicin—testicular cancer	0.000295	0.000341	CcSEcCtD
Topiramate—Oedema peripheral—Epirubicin—testicular cancer	0.000295	0.00034	CcSEcCtD
Topiramate—Haematuria—Doxorubicin—testicular cancer	0.000294	0.000339	CcSEcCtD
Topiramate—Connective tissue disorder—Epirubicin—testicular cancer	0.000294	0.000339	CcSEcCtD
Topiramate—Urethral disorder—Epirubicin—testicular cancer	0.000293	0.000339	CcSEcCtD
Topiramate—Epistaxis—Doxorubicin—testicular cancer	0.000291	0.000336	CcSEcCtD
Topiramate—Angiopathy—Methotrexate—testicular cancer	0.00029	0.000335	CcSEcCtD
Topiramate—Sinusitis—Doxorubicin—testicular cancer	0.000289	0.000334	CcSEcCtD
Topiramate—Immune system disorder—Methotrexate—testicular cancer	0.000289	0.000333	CcSEcCtD
Topiramate—Visual impairment—Epirubicin—testicular cancer	0.000288	0.000333	CcSEcCtD
Topiramate—Mediastinal disorder—Methotrexate—testicular cancer	0.000288	0.000333	CcSEcCtD
Topiramate—Agranulocytosis—Doxorubicin—testicular cancer	0.000288	0.000332	CcSEcCtD
Topiramate—Chills—Methotrexate—testicular cancer	0.000287	0.000331	CcSEcCtD
Topiramate—Nausea—Ifosfamide—testicular cancer	0.000285	0.000329	CcSEcCtD
Topiramate—Diarrhoea—Cisplatin—testicular cancer	0.000283	0.000327	CcSEcCtD
Topiramate—Erythema multiforme—Epirubicin—testicular cancer	0.000283	0.000327	CcSEcCtD
Topiramate—Alopecia—Methotrexate—testicular cancer	0.000282	0.000326	CcSEcCtD
Topiramate—Bradycardia—Doxorubicin—testicular cancer	0.000282	0.000325	CcSEcCtD
Topiramate—Mental disorder—Methotrexate—testicular cancer	0.00028	0.000323	CcSEcCtD
Topiramate—Eye disorder—Epirubicin—testicular cancer	0.000279	0.000323	CcSEcCtD
Topiramate—Hypersensitivity—Etoposide—testicular cancer	0.000279	0.000323	CcSEcCtD
Topiramate—Tinnitus—Epirubicin—testicular cancer	0.000279	0.000322	CcSEcCtD
Topiramate—Erythema—Methotrexate—testicular cancer	0.000278	0.000321	CcSEcCtD
Topiramate—Malnutrition—Methotrexate—testicular cancer	0.000278	0.000321	CcSEcCtD
Topiramate—Haemoglobin—Doxorubicin—testicular cancer	0.000278	0.000321	CcSEcCtD
Topiramate—Cardiac disorder—Epirubicin—testicular cancer	0.000278	0.000321	CcSEcCtD
Topiramate—Flushing—Epirubicin—testicular cancer	0.000278	0.000321	CcSEcCtD
Topiramate—Rhinitis—Doxorubicin—testicular cancer	0.000277	0.00032	CcSEcCtD
Topiramate—Haemorrhage—Doxorubicin—testicular cancer	0.000277	0.00032	CcSEcCtD
Topiramate—Hepatitis—Doxorubicin—testicular cancer	0.000277	0.00032	CcSEcCtD
Topiramate—Hypoaesthesia—Doxorubicin—testicular cancer	0.000275	0.000318	CcSEcCtD
Topiramate—Pharyngitis—Doxorubicin—testicular cancer	0.000275	0.000317	CcSEcCtD
Topiramate—Urinary tract disorder—Doxorubicin—testicular cancer	0.000273	0.000316	CcSEcCtD
Topiramate—Oedema peripheral—Doxorubicin—testicular cancer	0.000273	0.000315	CcSEcCtD
Topiramate—Dysgeusia—Methotrexate—testicular cancer	0.000272	0.000315	CcSEcCtD
Topiramate—Asthenia—Etoposide—testicular cancer	0.000272	0.000314	CcSEcCtD
Topiramate—Connective tissue disorder—Doxorubicin—testicular cancer	0.000272	0.000314	CcSEcCtD
Topiramate—Angiopathy—Epirubicin—testicular cancer	0.000271	0.000313	CcSEcCtD
Topiramate—Urethral disorder—Doxorubicin—testicular cancer	0.000271	0.000313	CcSEcCtD
Topiramate—Immune system disorder—Epirubicin—testicular cancer	0.00027	0.000312	CcSEcCtD
Topiramate—Mediastinal disorder—Epirubicin—testicular cancer	0.00027	0.000311	CcSEcCtD
Topiramate—Back pain—Methotrexate—testicular cancer	0.000269	0.000311	CcSEcCtD
Topiramate—Chills—Epirubicin—testicular cancer	0.000268	0.00031	CcSEcCtD
Topiramate—Pruritus—Etoposide—testicular cancer	0.000268	0.00031	CcSEcCtD
Topiramate—Visual impairment—Doxorubicin—testicular cancer	0.000267	0.000308	CcSEcCtD
Topiramate—Alopecia—Epirubicin—testicular cancer	0.000264	0.000305	CcSEcCtD
Topiramate—Vomiting—Cisplatin—testicular cancer	0.000263	0.000304	CcSEcCtD
Topiramate—Vision blurred—Methotrexate—testicular cancer	0.000262	0.000303	CcSEcCtD
Topiramate—Mental disorder—Epirubicin—testicular cancer	0.000262	0.000303	CcSEcCtD
Topiramate—Erythema multiforme—Doxorubicin—testicular cancer	0.000262	0.000302	CcSEcCtD
Topiramate—Rash—Cisplatin—testicular cancer	0.000261	0.000301	CcSEcCtD
Topiramate—Dermatitis—Cisplatin—testicular cancer	0.000261	0.000301	CcSEcCtD
Topiramate—Erythema—Epirubicin—testicular cancer	0.00026	0.000301	CcSEcCtD
Topiramate—Malnutrition—Epirubicin—testicular cancer	0.00026	0.000301	CcSEcCtD
Topiramate—Diarrhoea—Etoposide—testicular cancer	0.000259	0.0003	CcSEcCtD
Topiramate—Eye disorder—Doxorubicin—testicular cancer	0.000259	0.000299	CcSEcCtD
Topiramate—Ill-defined disorder—Methotrexate—testicular cancer	0.000258	0.000298	CcSEcCtD
Topiramate—Tinnitus—Doxorubicin—testicular cancer	0.000258	0.000298	CcSEcCtD
Topiramate—Anaemia—Methotrexate—testicular cancer	0.000257	0.000297	CcSEcCtD
Topiramate—Flushing—Doxorubicin—testicular cancer	0.000257	0.000297	CcSEcCtD
Topiramate—Cardiac disorder—Doxorubicin—testicular cancer	0.000257	0.000297	CcSEcCtD
Topiramate—Flatulence—Epirubicin—testicular cancer	0.000257	0.000296	CcSEcCtD
Topiramate—Tension—Epirubicin—testicular cancer	0.000255	0.000295	CcSEcCtD
Topiramate—Dysgeusia—Epirubicin—testicular cancer	0.000255	0.000294	CcSEcCtD
Topiramate—Nervousness—Epirubicin—testicular cancer	0.000253	0.000292	CcSEcCtD
Topiramate—Back pain—Epirubicin—testicular cancer	0.000252	0.000291	CcSEcCtD
Topiramate—Angiopathy—Doxorubicin—testicular cancer	0.000251	0.00029	CcSEcCtD
Topiramate—Malaise—Methotrexate—testicular cancer	0.000251	0.00029	CcSEcCtD
Topiramate—Dizziness—Etoposide—testicular cancer	0.000251	0.000289	CcSEcCtD
Topiramate—Muscle spasms—Epirubicin—testicular cancer	0.00025	0.000289	CcSEcCtD
Topiramate—Immune system disorder—Doxorubicin—testicular cancer	0.00025	0.000289	CcSEcCtD
Topiramate—Vertigo—Methotrexate—testicular cancer	0.00025	0.000289	CcSEcCtD
Topiramate—Mediastinal disorder—Doxorubicin—testicular cancer	0.000249	0.000288	CcSEcCtD
Topiramate—Leukopenia—Methotrexate—testicular cancer	0.000249	0.000288	CcSEcCtD
Topiramate—Chills—Doxorubicin—testicular cancer	0.000248	0.000287	CcSEcCtD
Topiramate—Nausea—Cisplatin—testicular cancer	0.000246	0.000284	CcSEcCtD
Topiramate—Vision blurred—Epirubicin—testicular cancer	0.000245	0.000283	CcSEcCtD
Topiramate—Alopecia—Doxorubicin—testicular cancer	0.000245	0.000282	CcSEcCtD
Topiramate—Cough—Methotrexate—testicular cancer	0.000243	0.00028	CcSEcCtD
Topiramate—Mental disorder—Doxorubicin—testicular cancer	0.000242	0.00028	CcSEcCtD
Topiramate—Ill-defined disorder—Epirubicin—testicular cancer	0.000242	0.000279	CcSEcCtD
Topiramate—Convulsion—Methotrexate—testicular cancer	0.000241	0.000278	CcSEcCtD
Topiramate—Vomiting—Etoposide—testicular cancer	0.000241	0.000278	CcSEcCtD
Topiramate—Malnutrition—Doxorubicin—testicular cancer	0.000241	0.000278	CcSEcCtD
Topiramate—Erythema—Doxorubicin—testicular cancer	0.000241	0.000278	CcSEcCtD
Topiramate—Anaemia—Epirubicin—testicular cancer	0.000241	0.000278	CcSEcCtD
Topiramate—Agitation—Epirubicin—testicular cancer	0.000239	0.000276	CcSEcCtD
Topiramate—Rash—Etoposide—testicular cancer	0.000239	0.000276	CcSEcCtD
Topiramate—Dermatitis—Etoposide—testicular cancer	0.000239	0.000276	CcSEcCtD
Topiramate—Headache—Etoposide—testicular cancer	0.000237	0.000274	CcSEcCtD
Topiramate—Flatulence—Doxorubicin—testicular cancer	0.000237	0.000274	CcSEcCtD
Topiramate—Myalgia—Methotrexate—testicular cancer	0.000237	0.000274	CcSEcCtD
Topiramate—Arthralgia—Methotrexate—testicular cancer	0.000237	0.000274	CcSEcCtD
Topiramate—Chest pain—Methotrexate—testicular cancer	0.000237	0.000274	CcSEcCtD
Topiramate—Tension—Doxorubicin—testicular cancer	0.000236	0.000273	CcSEcCtD
Topiramate—Dysgeusia—Doxorubicin—testicular cancer	0.000236	0.000272	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000235	0.000272	CcSEcCtD
Topiramate—Malaise—Epirubicin—testicular cancer	0.000235	0.000271	CcSEcCtD
Topiramate—Discomfort—Methotrexate—testicular cancer	0.000234	0.00027	CcSEcCtD
Topiramate—Nervousness—Doxorubicin—testicular cancer	0.000234	0.00027	CcSEcCtD
Topiramate—Vertigo—Epirubicin—testicular cancer	0.000234	0.00027	CcSEcCtD
Topiramate—Syncope—Epirubicin—testicular cancer	0.000233	0.00027	CcSEcCtD
Topiramate—Leukopenia—Epirubicin—testicular cancer	0.000233	0.000269	CcSEcCtD
Topiramate—Back pain—Doxorubicin—testicular cancer	0.000233	0.000269	CcSEcCtD
Topiramate—Muscle spasms—Doxorubicin—testicular cancer	0.000232	0.000267	CcSEcCtD
Topiramate—Palpitations—Epirubicin—testicular cancer	0.00023	0.000266	CcSEcCtD
Topiramate—Confusional state—Methotrexate—testicular cancer	0.000229	0.000264	CcSEcCtD
Topiramate—Loss of consciousness—Epirubicin—testicular cancer	0.000229	0.000264	CcSEcCtD
Topiramate—Cough—Epirubicin—testicular cancer	0.000227	0.000262	CcSEcCtD
Topiramate—Vision blurred—Doxorubicin—testicular cancer	0.000227	0.000262	CcSEcCtD
Topiramate—Convulsion—Epirubicin—testicular cancer	0.000226	0.000261	CcSEcCtD
Topiramate—Infection—Methotrexate—testicular cancer	0.000226	0.000261	CcSEcCtD
Topiramate—Nausea—Etoposide—testicular cancer	0.000225	0.00026	CcSEcCtD
Topiramate—Hypertension—Epirubicin—testicular cancer	0.000225	0.00026	CcSEcCtD
Topiramate—Ill-defined disorder—Doxorubicin—testicular cancer	0.000224	0.000258	CcSEcCtD
Topiramate—Nervous system disorder—Methotrexate—testicular cancer	0.000223	0.000257	CcSEcCtD
Topiramate—Anaemia—Doxorubicin—testicular cancer	0.000223	0.000257	CcSEcCtD
Topiramate—Thrombocytopenia—Methotrexate—testicular cancer	0.000222	0.000257	CcSEcCtD
Topiramate—Myalgia—Epirubicin—testicular cancer	0.000222	0.000256	CcSEcCtD
Topiramate—Chest pain—Epirubicin—testicular cancer	0.000222	0.000256	CcSEcCtD
Topiramate—Arthralgia—Epirubicin—testicular cancer	0.000222	0.000256	CcSEcCtD
Topiramate—Agitation—Doxorubicin—testicular cancer	0.000221	0.000256	CcSEcCtD
Topiramate—Anxiety—Epirubicin—testicular cancer	0.000221	0.000255	CcSEcCtD
Topiramate—Skin disorder—Methotrexate—testicular cancer	0.000221	0.000255	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00022	0.000254	CcSEcCtD
Topiramate—Hyperhidrosis—Methotrexate—testicular cancer	0.000219	0.000253	CcSEcCtD
Topiramate—Discomfort—Epirubicin—testicular cancer	0.000219	0.000253	CcSEcCtD
Topiramate—Malaise—Doxorubicin—testicular cancer	0.000217	0.000251	CcSEcCtD
Topiramate—Dry mouth—Epirubicin—testicular cancer	0.000217	0.00025	CcSEcCtD
Topiramate—Vertigo—Doxorubicin—testicular cancer	0.000216	0.00025	CcSEcCtD
Topiramate—Anorexia—Methotrexate—testicular cancer	0.000216	0.00025	CcSEcCtD
Topiramate—Syncope—Doxorubicin—testicular cancer	0.000216	0.000249	CcSEcCtD
Topiramate—Leukopenia—Doxorubicin—testicular cancer	0.000216	0.000249	CcSEcCtD
Topiramate—Confusional state—Epirubicin—testicular cancer	0.000214	0.000247	CcSEcCtD
Topiramate—Palpitations—Doxorubicin—testicular cancer	0.000213	0.000246	CcSEcCtD
Topiramate—Oedema—Epirubicin—testicular cancer	0.000212	0.000245	CcSEcCtD
Topiramate—Hypotension—Methotrexate—testicular cancer	0.000212	0.000245	CcSEcCtD
Topiramate—Loss of consciousness—Doxorubicin—testicular cancer	0.000212	0.000245	CcSEcCtD
Topiramate—Infection—Epirubicin—testicular cancer	0.000211	0.000244	CcSEcCtD
Topiramate—Cough—Doxorubicin—testicular cancer	0.00021	0.000243	CcSEcCtD
Topiramate—Shock—Epirubicin—testicular cancer	0.000209	0.000241	CcSEcCtD
Topiramate—Convulsion—Doxorubicin—testicular cancer	0.000209	0.000241	CcSEcCtD
Topiramate—Nervous system disorder—Epirubicin—testicular cancer	0.000208	0.000241	CcSEcCtD
Topiramate—Thrombocytopenia—Epirubicin—testicular cancer	0.000208	0.00024	CcSEcCtD
Topiramate—Hypertension—Doxorubicin—testicular cancer	0.000208	0.00024	CcSEcCtD
Topiramate—Tachycardia—Epirubicin—testicular cancer	0.000207	0.000239	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000207	0.000239	CcSEcCtD
Topiramate—Skin disorder—Epirubicin—testicular cancer	0.000206	0.000238	CcSEcCtD
Topiramate—Hyperhidrosis—Epirubicin—testicular cancer	0.000205	0.000237	CcSEcCtD
Topiramate—Insomnia—Methotrexate—testicular cancer	0.000205	0.000237	CcSEcCtD
Topiramate—Myalgia—Doxorubicin—testicular cancer	0.000205	0.000237	CcSEcCtD
Topiramate—Chest pain—Doxorubicin—testicular cancer	0.000205	0.000237	CcSEcCtD
Topiramate—Arthralgia—Doxorubicin—testicular cancer	0.000205	0.000237	CcSEcCtD
Topiramate—Anxiety—Doxorubicin—testicular cancer	0.000204	0.000236	CcSEcCtD
Topiramate—Paraesthesia—Methotrexate—testicular cancer	0.000204	0.000235	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000204	0.000235	CcSEcCtD
Topiramate—Discomfort—Doxorubicin—testicular cancer	0.000203	0.000234	CcSEcCtD
Topiramate—Anorexia—Epirubicin—testicular cancer	0.000203	0.000234	CcSEcCtD
Topiramate—Dyspnoea—Methotrexate—testicular cancer	0.000202	0.000234	CcSEcCtD
Topiramate—Somnolence—Methotrexate—testicular cancer	0.000202	0.000233	CcSEcCtD
Topiramate—Dry mouth—Doxorubicin—testicular cancer	0.000201	0.000232	CcSEcCtD
Topiramate—Dyspepsia—Methotrexate—testicular cancer	0.0002	0.000231	CcSEcCtD
Topiramate—Hypotension—Epirubicin—testicular cancer	0.000199	0.000229	CcSEcCtD
Topiramate—Confusional state—Doxorubicin—testicular cancer	0.000198	0.000229	CcSEcCtD
Topiramate—Decreased appetite—Methotrexate—testicular cancer	0.000197	0.000228	CcSEcCtD
Topiramate—Oedema—Doxorubicin—testicular cancer	0.000197	0.000227	CcSEcCtD
Topiramate—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000196	0.000226	CcSEcCtD
Topiramate—Fatigue—Methotrexate—testicular cancer	0.000196	0.000226	CcSEcCtD
Topiramate—Infection—Doxorubicin—testicular cancer	0.000195	0.000226	CcSEcCtD
Topiramate—Pain—Methotrexate—testicular cancer	0.000194	0.000224	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000194	0.000224	CcSEcCtD
Topiramate—Shock—Doxorubicin—testicular cancer	0.000193	0.000223	CcSEcCtD
Topiramate—Nervous system disorder—Doxorubicin—testicular cancer	0.000193	0.000223	CcSEcCtD
Topiramate—Thrombocytopenia—Doxorubicin—testicular cancer	0.000192	0.000222	CcSEcCtD
Topiramate—Insomnia—Epirubicin—testicular cancer	0.000192	0.000222	CcSEcCtD
Topiramate—Tachycardia—Doxorubicin—testicular cancer	0.000192	0.000222	CcSEcCtD
Topiramate—Skin disorder—Doxorubicin—testicular cancer	0.000191	0.000221	CcSEcCtD
Topiramate—Paraesthesia—Epirubicin—testicular cancer	0.000191	0.00022	CcSEcCtD
Topiramate—Hyperhidrosis—Doxorubicin—testicular cancer	0.00019	0.000219	CcSEcCtD
Topiramate—Dyspnoea—Epirubicin—testicular cancer	0.000189	0.000219	CcSEcCtD
Topiramate—Somnolence—Epirubicin—testicular cancer	0.000189	0.000218	CcSEcCtD
Topiramate—Anorexia—Doxorubicin—testicular cancer	0.000187	0.000216	CcSEcCtD
Topiramate—Feeling abnormal—Methotrexate—testicular cancer	0.000187	0.000216	CcSEcCtD
Topiramate—Dyspepsia—Epirubicin—testicular cancer	0.000187	0.000216	CcSEcCtD
Topiramate—Gastrointestinal pain—Methotrexate—testicular cancer	0.000186	0.000214	CcSEcCtD
Topiramate—Decreased appetite—Epirubicin—testicular cancer	0.000185	0.000213	CcSEcCtD
Topiramate—Hypotension—Doxorubicin—testicular cancer	0.000184	0.000212	CcSEcCtD
Topiramate—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000183	0.000212	CcSEcCtD
Topiramate—Fatigue—Epirubicin—testicular cancer	0.000183	0.000212	CcSEcCtD
Topiramate—Pain—Epirubicin—testicular cancer	0.000182	0.00021	CcSEcCtD
Topiramate—Constipation—Epirubicin—testicular cancer	0.000182	0.00021	CcSEcCtD
Topiramate—Urticaria—Methotrexate—testicular cancer	0.00018	0.000208	CcSEcCtD
Topiramate—Abdominal pain—Methotrexate—testicular cancer	0.000179	0.000207	CcSEcCtD
Topiramate—Body temperature increased—Methotrexate—testicular cancer	0.000179	0.000207	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000179	0.000207	CcSEcCtD
Topiramate—Insomnia—Doxorubicin—testicular cancer	0.000178	0.000205	CcSEcCtD
Topiramate—Paraesthesia—Doxorubicin—testicular cancer	0.000177	0.000204	CcSEcCtD
Topiramate—Dyspnoea—Doxorubicin—testicular cancer	0.000175	0.000202	CcSEcCtD
Topiramate—Feeling abnormal—Epirubicin—testicular cancer	0.000175	0.000202	CcSEcCtD
Topiramate—Somnolence—Doxorubicin—testicular cancer	0.000175	0.000202	CcSEcCtD
Topiramate—Gastrointestinal pain—Epirubicin—testicular cancer	0.000174	0.000201	CcSEcCtD
Topiramate—Dyspepsia—Doxorubicin—testicular cancer	0.000173	0.0002	CcSEcCtD
Topiramate—Decreased appetite—Doxorubicin—testicular cancer	0.000171	0.000197	CcSEcCtD
Topiramate—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.00017	0.000196	CcSEcCtD
Topiramate—Fatigue—Doxorubicin—testicular cancer	0.00017	0.000196	CcSEcCtD
Topiramate—Urticaria—Epirubicin—testicular cancer	0.000169	0.000195	CcSEcCtD
Topiramate—Constipation—Doxorubicin—testicular cancer	0.000168	0.000194	CcSEcCtD
Topiramate—Pain—Doxorubicin—testicular cancer	0.000168	0.000194	CcSEcCtD
Topiramate—Abdominal pain—Epirubicin—testicular cancer	0.000168	0.000194	CcSEcCtD
Topiramate—Body temperature increased—Epirubicin—testicular cancer	0.000168	0.000194	CcSEcCtD
Topiramate—Hypersensitivity—Methotrexate—testicular cancer	0.000167	0.000193	CcSEcCtD
Topiramate—Asthenia—Methotrexate—testicular cancer	0.000163	0.000188	CcSEcCtD
Topiramate—Feeling abnormal—Doxorubicin—testicular cancer	0.000162	0.000187	CcSEcCtD
Topiramate—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000161	0.000186	CcSEcCtD
Topiramate—Pruritus—Methotrexate—testicular cancer	0.000161	0.000186	CcSEcCtD
Topiramate—Hypersensitivity—Epirubicin—testicular cancer	0.000157	0.000181	CcSEcCtD
Topiramate—Urticaria—Doxorubicin—testicular cancer	0.000156	0.00018	CcSEcCtD
Topiramate—Abdominal pain—Doxorubicin—testicular cancer	0.000155	0.000179	CcSEcCtD
Topiramate—Body temperature increased—Doxorubicin—testicular cancer	0.000155	0.000179	CcSEcCtD
Topiramate—Diarrhoea—Methotrexate—testicular cancer	0.000155	0.000179	CcSEcCtD
Topiramate—Asthenia—Epirubicin—testicular cancer	0.000152	0.000176	CcSEcCtD
Topiramate—Pruritus—Epirubicin—testicular cancer	0.00015	0.000174	CcSEcCtD
Topiramate—Dizziness—Methotrexate—testicular cancer	0.00015	0.000173	CcSEcCtD
Topiramate—Diarrhoea—Epirubicin—testicular cancer	0.000145	0.000168	CcSEcCtD
Topiramate—Hypersensitivity—Doxorubicin—testicular cancer	0.000145	0.000167	CcSEcCtD
Topiramate—Vomiting—Methotrexate—testicular cancer	0.000144	0.000167	CcSEcCtD
Topiramate—Rash—Methotrexate—testicular cancer	0.000143	0.000165	CcSEcCtD
Topiramate—Dermatitis—Methotrexate—testicular cancer	0.000143	0.000165	CcSEcCtD
Topiramate—Headache—Methotrexate—testicular cancer	0.000142	0.000164	CcSEcCtD
Topiramate—Asthenia—Doxorubicin—testicular cancer	0.000141	0.000163	CcSEcCtD
Topiramate—Dizziness—Epirubicin—testicular cancer	0.000141	0.000162	CcSEcCtD
Topiramate—Pruritus—Doxorubicin—testicular cancer	0.000139	0.000161	CcSEcCtD
Topiramate—Vomiting—Epirubicin—testicular cancer	0.000135	0.000156	CcSEcCtD
Topiramate—Nausea—Methotrexate—testicular cancer	0.000135	0.000156	CcSEcCtD
Topiramate—Diarrhoea—Doxorubicin—testicular cancer	0.000135	0.000155	CcSEcCtD
Topiramate—Rash—Epirubicin—testicular cancer	0.000134	0.000155	CcSEcCtD
Topiramate—Dermatitis—Epirubicin—testicular cancer	0.000134	0.000155	CcSEcCtD
Topiramate—Headache—Epirubicin—testicular cancer	0.000133	0.000154	CcSEcCtD
Topiramate—Dizziness—Doxorubicin—testicular cancer	0.00013	0.00015	CcSEcCtD
Topiramate—Nausea—Epirubicin—testicular cancer	0.000126	0.000146	CcSEcCtD
Topiramate—Vomiting—Doxorubicin—testicular cancer	0.000125	0.000144	CcSEcCtD
Topiramate—Rash—Doxorubicin—testicular cancer	0.000124	0.000143	CcSEcCtD
Topiramate—Dermatitis—Doxorubicin—testicular cancer	0.000124	0.000143	CcSEcCtD
Topiramate—Headache—Doxorubicin—testicular cancer	0.000123	0.000142	CcSEcCtD
Topiramate—Nausea—Doxorubicin—testicular cancer	0.000117	0.000135	CcSEcCtD
